PRESCRIPTION PATTERN OF CARDIOVASCULAR AND/OR ANTIDIABETIC DRUGS IN ABUJA DISTRICT HOSPITALS

  • NKEIRUKA GRACE OSUAFOR Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, PMB 410001 Enugu State, Nigeria
  • CHINWE VICTORIA UKWE Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, PMB 410001 Enugu State, Nigeria
  • MATTEW JEGBEFUME OKONTA Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka, PMB 410001 Enugu State, Nigeria

Abstract

Objective: The study aimed to describe the prescription pattern of cardiovascular and/or anti-diabetic drugs and adherence to the World Health Organization (WHO) prescribing indicators in Abuja District Hospitals.


Methods: This descriptive retrospective study was carried out in Asokoro and Maitama District Hospitals Abuja. One thousand and nine prescriptions that contained a cardiovascular drug (CVD) and/or anti-diabetic drug issued between June 2017 and May 2018 from the Medical Outpatient Department were analyzed. Data were collected from the pharmacy electronic database, prescription pattern and adherence to WHO prescribing indicators were assessed. The analysis was done using descriptive statistics. Results were presented as percentages, means, and standard deviations.


Results: The frequency of treatment was higher among women (58.8%) and the age group of 41–60 (54.8%). The average number of drugs prescribed was 3.3±1.6: the percentage of drugs prescribed in generic was (64%) and (78.8%) were from the Essential Drug List (EDL). Calcium Channel Blockers (CCB, 71.7%) and Biguanides (B, 92.4%) were the most prescribed CVD and anti-diabetic drug. The majority of the CVD (74.5%) and diabetes (63.6%) patients were on combination therapy. The most frequent CVD combination was CCB plus Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers (29.7%). Compared to men, the proportion of females taking one or more CVD (61.3%) or antidiabetic (56.4%) was higher.


Conclusion: The prescribing indicators are not optimal in Abuja district hospitals. Women received more treatment for cardiovascular and diabetes diseases than men while the age range of 41-60 was more treated than other age groups.

Keywords: Cardiovascular, Anti-diabetic, Prescription pattern, Prescribing indicators, District hospitals

Downloads

Download data is not yet available.

References

1. WHO. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016. Geneva; 2018.
2. Maiyaki M, Garbati M. The burden of non-communicable diseases in Nigeria: in the context of globalization. Ann Afr Med 2014;13:1–0.
3. WHO. Global Health Estimates 2016: Disease burden by Cause, Age, Sex, by Country and by Region, 2000-2016. Geneva; 2018.
4. Akinlua JT, Meakin R, Umar AM, Freemantle N. Current prevalence pattern of hypertension in nigeria: a systematic review. PLoS One 2015;10:1–8.
5. Ekpenyong CE, Udokang NE, Akpan EE, Samson TK. Double burden, non-communicable diseases, and risk factors evaluation in sub-saharan Africa: the Nigerian experience. Eur J Sustain Dev 2012;1:249–70.
6. International Diabetes Federation. 5th IDF diabetes atlas; 2011. p. 106.
7. Uloko AE, Musa BM, Ramalan MA. Prevalence and risk factors for diabetes mellitus in Nigeria?: a systematic review and meta-analysis. Diabetes Ther 2018;9:1307–16.
8. Karimi A, Haerizadeh M, Soleymani F, Haerizadeh M, Taheri F. Evaluation of medicine prescription pattern using World Health Organization prescribing indicators in Iran?: a cross-sectional study. J Res Pharm Pract 2014;3:39–45.
9. Khrime D, Kumar A, Pandey AN, Bansal N, Sharma U, Varma A. Antihypertensive drug utilization pattern and awareness in diabetic hypertensive patients at a tertiary care center. Int J Res Med Sci 2015;3:461–5.
10. WHO. How to investigate drug use in health facilities. Geneva; 1993.
11. Bhavika D, Prasanna V, Swathi B. Drug utilization study of antihypertensive drugs in a tertiary care hospital. Int J Basic Clin Pharmacol 2016;5:1580–5.
12. Datta S. Utilization study of antihypertensives in a South Indian Tertiary Care Teaching Hospital and adherence to standard treatment guidelines. J Basic Clin Pharm 2017;8:33–7.
13. Ekwunife OI, Ubaka CM. Drug utilization review of antihypertensive therapy among patients with compelling indications in two hospitals in South-Eastern Nigeria. J Pharm Pharmacol Res 2011;2:25–8.
14. Riaz H, Brian G, Sajid B, Shahzad H, Mahmood S, Durdana. Evaluation of drug use indicators for non-communicable diseases in Pakistan. Acta Pol Pharm Res 2016;73:787–94.
15. Jainaf Nachiya RAM, Parimalakrishnan S, Ramakrishna RM. Study on drug utilization pattern of antihypertensive medications on out-patients and inpatients in a tertiary care teaching hospital: a cross-sectional study. Afr J Pharm Pharmacol 2015;9:383–96.
16. Ukwe CV, Ubaka CM. Antihypertensive drug prescribing in a tertiary hospital in eastern Nigeria. Trop J Pharm Res 2012;11:297–305.
17. Nwaka AL, Nduka SO, Osonwa UE, Anetoh M, Uzodinma U, Ele GN. Evaluation of the prescription pattern of antihypertensive agents in a tertiary health institution in Nigeria. Afr J Pharm Pharmacol 2015;9:540–6.
18. Agarwal AA, Jadhav PR, Deshmukh YA. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients. J Basic Clin Pharm 2014;5:79–83.
19. Adibe MO, Aguwa CN, Ukwe CV, Okonta JM. Outpatient utilization of anti-diabetic drugs in southeastern Nigeria. Int J Drug Dev Res 2009;1:27–36.
20. Okoro NR, Nmeka C, Erah PO. Utilization study of anti-diabetes medicines at a tertiary care hospital in Nigeria. Futur J Pharm Sci 2017;4:109-15.
21. Lee SY, Bae J, Cho M, Lim NK, Park H. Antihypertensive drug use and gender difference in real-world practice: a Korean national health insurance database study. J Hypertens 2016;34:9-15.
22. Murti K, Khan MA, Dey A, Sethi MK, Das P, Pandey K. Prescription pattern of antihypertensive drugs and adherence to JNC-7 guidelines. Am J Pharmacol Toxicol 2015;10:27-31.
23. WHO. Non-communicable diseases country profiles; 2014. p. 323.
24. Atif M, Sarwar MR, Azeem M, Naz M, Amir S, Nazir K. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res 2016;16:684.
25. Eze UIH, Olowu AO. Prescribing patterns and inappropriate use of medications in elderly outpatients in a tertiary hospital in Nigeria. Trop J Pharm Res 2011;10:19–25.
26. Adisa R, Fakeye TO, Aindero VO. Evaluation of prescription pattern and patients’ opinion on healthcare practices in selected primary healthcare facilities in Ibadan, South-Western Nigeria. Afr Heal Sci 2015;15:1318–29.
27. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Arbor A, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. US Dep Heal Hum Serv 2004. p. 49.
28. Chinenye S, Ofoegbu E, Uloko A, Ogbera A, Kuku S, Johnson TO. Clinical practice guidelines for diabetes management in Nigeria. 2nd ed. Diabetes Association of Nigeria; 2013. p. 28.
29. Bramlage P, Schmidt S, Sims H. Fixed-dose vs free­dose combinations for the management of hypertension-An analysis of 81 958 patients. J Clin Hypertens 2018;20:705–15.
30. Ilesanmi SO, Ige Ok, Adebiyi AO. The managed hypertensive: the costs of blood pressure control in a Nigerian town. Pan Afr Med J 2012;12:96.
31. Bilal AI, Osman ED, Mulugeta A. Assessment of medicines use pattern using World Health Organization's prescribing, patient care and health facility indicators in selected health facilities in eastern Ethiopia. BMC Health Serv Res 2016;16:144-50.
32. Tamuno I, Fadare JO. Drug prescription pattern in a Nigerian tertiary hospital. Trop J Pharm Res 2012;11:146–52.
33. Atif M, Sarwar MR, Azeem M, Umer D, Rauf A, Rasool A, et al. Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab Pakistan. J Pharm Policy Pract 2016;9:27.
34. Aravamuthan A, Arputhavanan M, Subramaniam K. Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India. J Pharm Policy Pract 2017;10:1–6.
35. Sharif SI, Alabdouli AH, Sharif RS. Drug prescribing trends in a general hospital in Sharjah, United Arab Emirates. Am J Pharmacol Sci 2013;1:6-9.
36. Aki OA, El Mahalli AA, Awad A, Elkahky A. WHO/INRUD drug use indicators at primary healthcare centers in Alexandria, Egypt. J Taibah Univ Med Sci 2014;9:54-64.
37. Flood D, Mathieu I, Chary A, García P, Rohloff P. Perceptions and utilization of generic medicines in guatemala: a mixed-methods study with physicians and pharmacy staff. BMC Health Serv Res 2017;17:27.
38. Desalegn AA. Assessment of drug use patterns using WHO prescribing indicators at Hawassa University teaching and referral hospital, South Ethiopia: a cross-sectional study. BMC Health Serv Res 2013;13:170.
39. JM Okonta, SO Nduka, VE Idodo. Prescribing pattern of antihypertensive and antidiabetic agents in a secondary healthcare institution in Nigeria. J Pharm Sci Res 2013;5:12-7.
40. Panda BB, Pati MR, Sahu PK. Survey of prescription pattern of antihypertensive drugs in hypertensive and diabetic hypertensive patients. Asian J Pharm Clin Res 2015;8:250-2.
41. Alba Leonel A, Carvajal A, Fierro I, Castillo NF. Prescription patterns of antihypertensives in a community health center in mexico city: a drug utilization study. Authors Fundam Clin Pharmacol 2016;30:276–81.
42. Oh GC, Lee H, Chung WJ, Youn H, Cho E, Sung K, et al. Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial. Clin Hypertens 2017;23:18.
43. Holman RR, Paul SK, Bethel AM, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. New Engl J Med 2008;359:1577–89.
44. Bakare OQ, Goodman O, Kuyinu YA, Wright OK, Adeniran A, Odusanya OO. Antihypertensive use, prescription patterns, and cost of medications in a teaching hospital in lagos, nigeria. Niger J Clin Prac 2016;19:688–72.
45. Etuk E, Isezuo SA, Chika A, Akuche J, Ali M. Prescription pattern of antihypertensive drugs in a tertiary health institution in Nigeria. Ann Afr Med 2008;7:128–32.
46. Mahanjit K, Pranab KP, SwarnamonI D. Prescribing pattern of antihypertensive drugs in essential hypertension in medicine out patients department in a tertiary care hospital. Asian Pharm Clin Res 2014;7 Suppl 2:142-4.
47. Patel B, Oza B, Patel KP, Malhotra SD, Patel VJ. Pattern of antidiabetic drugs use in type-2 diabetic patients in a medical outpatient clinic of a tertiary care teaching hospital. Int J Basic Clin Pharmacol 2013;2:485–91.
48. Gu Q, Burt VL, Paulose Ram R, Dillon CF. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and nutrition examination survey 1999-2004. Am J Hypertens 2008;21:787-98.
49. McCall AL. Insulin therapy and hypoglycemia. Endocrinol Metab Clin North Am 2012;41:57–87.
50. Hope SV, Taylor PJ, Shields BM, Hattersley AT, Hamilton W, Practice M, et al. Are we missing hypoglycemia? elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycemia. Prim Care Diabe 2017;12:139–46.
Statistics
134 Views | 55 Downloads
Citatons
How to Cite
OSUAFOR, N. G., C. V. UKWE, and M. J. OKONTA. “PRESCRIPTION PATTERN OF CARDIOVASCULAR AND/OR ANTIDIABETIC DRUGS IN ABUJA DISTRICT HOSPITALS”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 11, no. 9, July 2019, pp. 21-27, doi:10.22159/ijpps.2019v11i9.34525.
Section
Original Article(s)